Amgen's NESP victory cuts out Johnson and Johnson

Article Abstract:

Thousand Oaks, CA-based Amgen has been awarded by a panel in Chicago exclusive rights to its next-generation anemia drug, novel erythropoiesis-stimulating protein (NESP). The panel rejected the claim of New Brunswick, NJ-based Johnson and Johnson that the drug falls under a 1985 license agreement between the two companies for erythropoietin (EPO). The decision gives Amgen a monopoly over the expected blockbuster drug, caused the company's stock to rise, and probably averted a hostile takeover by Johnson and Johnson.

Comment:

Thousand Oaks, CA-based Amgen has been awarded by a panel in Chicago exclusive rights to its next-generation anemia drug, novel erythropoiesis-stimulating protein (NESP).

Plasma Protein Fraction, Johnson & Johnson, JNJ, Blood proteins

---

Adding new meanings to the genetic code

Article Abstract:

Understanding of biological structure-function relationships has been greatly enhanced by the use of site-directed mutagenesis to exchange one or more amino acids at any given position in a protein.

Science & research, Drugs, Deoxyribonucleic Acid, DNA

---

Ruling favors Amgen

Article Abstract:

The U.S. District Court in Massachusetts ruled in favor of Amgen's erythropoietin patent suit against Transkaryotic Therapies and its partner Aventis Pharma.

Massachusetts, Transkaryotic Therapies Inc., Aventis Pharma AG

Similar abstracts:

• Abstracts: Pumped up for success. Going against the grain. Enter the dragon: how a Saskatchewan CA gets his kicks
• Abstracts: Pulling out of Asia. Fading jewel in the crown. The buyside begins
• Abstracts: The IASC's long march towards harmonization. Right idea, shame about the politics. US puts pressure on the IASC
• Abstracts: Anthropometry of South Indian industrial workmen. Ready steady push - a study of the arm posture in manual exertions
• Abstracts: Stock option planning. 1999 - the year of the hare. The fiendishly complex, unnecessarily burdensome, frustrating and ensnaring individual alternative minimum tax

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.